A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2002
09/12/2002	CA2439691A1 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
09/12/2002	CA2439682A1 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity
09/12/2002	CA2439681A1 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell
09/12/2002	CA2439636A1 Mouse cytokine receptor
09/12/2002	CA2439628A1 Vaccine
09/12/2002	CA2439625A1 Compositions of multimeric profilin for diagnosis and treatment of allergies
09/12/2002	CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof
09/12/2002	CA2439584A1 Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
09/12/2002	CA2439456A1 Novel abcg4 transporter and uses thereof
09/12/2002	CA2439293A1 Enteral formulation
09/12/2002	CA2439205A1 Nuclear hormone receptor ligand binding domain
09/12/2002	CA2439203A1 Nuclear hormone receptor ligand binding domain
09/12/2002	CA2439200A1 Nuclear hormone receptor ligand binding domain
09/12/2002	CA2439197A1 Nuclear hormone receptor ligand binding domain
09/12/2002	CA2439196A1 Nuclear hormone receptor ligand binding domains
09/12/2002	CA2439195A1 Nuclear hormone receptor ligand binding domain
09/12/2002	CA2439192A1 Nuclear hormone receptor ligand binding domain
09/12/2002	CA2439178A1 Template-fixed peptidomimetics with antimicrobial activity
09/12/2002	CA2438849A1 Compounds and compositions for delivering active agents
09/12/2002	CA2438326A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
09/12/2002	CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
09/12/2002	CA2437398A1 Molecules for disease detection and treatment
09/12/2002	CA2435277A1 Chimeric polypeptides of serum albumin and uses related thereto
09/12/2002	CA2434601A1 Methods for specifically inhibiting histone deacetylase-4
09/12/2002	CA2434184A1 Bisaryl derivatives having fsh receptor modulatory activity
09/12/2002	CA2433933A1 Use of lp82 to treat hematopoietic disorders
09/12/2002	CA2432280A1 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
09/12/2002	CA2431500A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
09/12/2002	CA2428798A1 Fen-1 endonucleases from archaeoglobus veneficus
09/11/2002	EP1239051A2 Human posh-like protein 1
09/11/2002	EP1239050A1 Method of testing remedy or preventive for hyperlipemia
09/11/2002	EP1239043A2 Fusion proteins comprising tumour necrosis factor receptor
09/11/2002	EP1239042A1 Transposase and method of gene modification
09/11/2002	EP1239039A1 Novel polypeptide and dna thereof
09/11/2002	EP1239038A1 High-throughput identification of modulators of e2f activity
09/11/2002	EP1239036A1 Polynucleotides, polypeptides, remedies for cancer and vaccines
09/11/2002	EP1239034A2 Large circular target-specific antisense nucleic acids
09/11/2002	EP1238986A2 Use of Vascular endothelial cell growth factor antagonists
09/11/2002	EP1238984A1 54498, an amino acid transporter and uses therefor
09/11/2002	EP1238678A1 Enzyme-activated cytostatic conjugates with integrin ligands
09/11/2002	EP1238675A1 Recombinant gelatin-like proteins for use as plasma expanders
09/11/2002	EP1238674A2 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF
09/11/2002	EP1238660A1 Sustained delivery of an active agent using an implantable system
09/11/2002	EP1238659A1 Sustained delivery of an active agent using an implantable system
09/11/2002	EP1238658A1 Sustained delivery of an active agent using an implantable system
09/11/2002	EP1238657A1 Sustained delivery of an active agent using an implantable system
09/11/2002	EP1238656A1 Sustained delivery of an active agent using an implantable system
09/11/2002	EP1238655A1 Composition containing a derivative of polyamino acids, and use of this compound to combat skin wrinkles
09/11/2002	EP1238281A2 Cancer associated antigens and uses therefor
09/11/2002	EP1238104A2 Agents implicated in endometriosis
09/11/2002	EP1238095A2 Compositions and methods for caspase-induced apoptosis
09/11/2002	EP1238092A2 Bovine immunodeficiency virus (biv) based vectors
09/11/2002	EP1238089A2 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases
09/11/2002	EP1238087A2 Porcine endovirus gag and env and diagnostic uses thereof
09/11/2002	EP1238084A2 Compounds and methods for treatment and diagnosis of chlamydial infection
09/11/2002	EP1238082A2 Ifn-alpha homologues
09/11/2002	EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use
09/11/2002	EP1238078A2 Clasp-4 transmembrane protein
09/11/2002	EP1238077A1 Tnfr/opg-like molecules and uses thereof
09/11/2002	EP1238075A2 Chordin-like molecules and uses thereof
09/11/2002	EP1238073A2 A eag gene encoding for a potassium channel
09/11/2002	EP1238072A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
09/11/2002	EP1238071A2 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses
09/11/2002	EP1238070A2 Therapeutically useful synthetic oligonucleotides
09/11/2002	EP1238069A2 Antisense oligonucleotides for metabotropic glutamate receptor type 1 (mglur1)
09/11/2002	EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it
09/11/2002	EP1238063A2 Tankyrase h, compositions involved in the cell cycle and methods of use
09/11/2002	EP1238058A2 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation
09/11/2002	EP1237936A1 Molecularly inprinted polymers produced by template polymerisation
09/11/2002	EP1237930A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization
09/11/2002	EP1237922A2 Proteoglycans and pharmaceutical compositions comprising them
09/11/2002	EP1237920A2 A NOVEL METHOD TO PRODUCE HUMAN NATURAL INTERFERON-$g(a)
09/11/2002	EP1237919A1 Interferon-alpha induced gene
09/11/2002	EP1237918A2 A gene, disrupted in schizophrenia
09/11/2002	EP1237917A2 Protein c derivatives
09/11/2002	EP1237916A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use
09/11/2002	EP1237915A2 Polynucleotid encoding the rg1 polypeptide
09/11/2002	EP1237914A1 Methods for improving secondary metabolite production in fungi
09/11/2002	EP1237913A2 Antigen preparations
09/11/2002	EP1237912A2 Five-helix protein
09/11/2002	EP1237910A2 Trp-protein-related mtr1 protein and dna sequence coding therefor
09/11/2002	EP1237901A1 28 human secreted proteins
09/11/2002	EP1237900A1 Subunit optimized fusion proteins
09/11/2002	EP1237897A2 Antithrombotic compound
09/11/2002	EP1237880A2 Pyrazine based inhibitors of glycogen synthase kinase 3
09/11/2002	EP1237878A2 4-pyrimidinyl-n-acyl-l-phenylalanines
09/11/2002	EP1237698A2 Water unstable foam compositions
09/11/2002	EP1237582A2 Methods for introducing genes into mammalian subjects
09/11/2002	EP1237581A1 Use of cationic lipids for intracellular protein delivery
09/11/2002	EP1237580A2 Amphiphilic polymers and polypeptide conjugates comprising same
09/11/2002	EP1237575A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
09/11/2002	EP1237569A1 An additive for an animal feed
09/11/2002	EP1237568A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance
09/11/2002	EP1237567A2 Method for administering a cytokine to the central nervous system and the lymphatic system
09/11/2002	EP1237566A2 Intraspinal compositions containing botulinum toxin for treating pain
09/11/2002	EP1237563A1 Nutritional composition, methods of producing said composition and methods of using said composition
09/11/2002	EP1237559A1 Pharmaceutical combinations
09/11/2002	EP1237558A1 Novel helicobacter pylori-binding substances and use thereof
09/11/2002	EP1237546A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases
09/11/2002	EP1237408A2 Pour-on formulations

1 ... 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 ... 3163